Audited Results of Procter & Gamble Health Ltd. Company

(Rs in Cr.)	Mar 31, 2026	Mar 31, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
Operating Income	1,407.97	934.17	1,151.26	1,229.62	1,114.41
Manufacturing Expenses	7.33	5.82	8.50	12.88	14.70
Personnel Expenses	222.56	142.06	215.16	206.17	167.56
Selling Expenses	88.90	42.33	52.65	74.49	109.45
Administrative Expenses	261.23	161.76	231.74	243.36	209.57
Expenses Capitalised	0	0	0	0	0
Cost Of Sales	951.31	615.78	845.26	904.94	846.73
Operating Profit	456.66	318.39	306	324.68	267.68
Other Recurring Income	17.34	10.35	15.63	18.39	13.19
Adjusted PBDIT	474	328.74	321.63	343.07	280.87
Financial Expenses	0.55	0.43	0.72	0.77	0.42
Depreciation	23.59	16.69	27.40	28.10	27.08
Other Write offs	0	0	0	0	0
Adjusted PBT	449.86	311.62	293.51	314.20	253.37
Tax Charges	122.95	77.21	72.34	84.73	60.85
Adjusted PAT	326.91	234.41	221.17	229.47	192.52
Non Recurring Items	-0.28	-2.62	-19.52	-1.84	0.70
Other Non Cash adjustments	0	0	0	0	0
Reported Net Profit	326.91	234.41	200.98	229.47	192.52
Equity Dividend	340.28	232.40	414.99	93.79	283.85
Preference Dividend	0	0	0	0	0
Retained Earnings	146.28	156.96	157.57	370.91	237.07

Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article